Wittwer, Nina L. https://orcid.org/0000-0002-3515-6043
Meier, Christoph R. https://orcid.org/0000-0002-7120-6378
Huber, Carola A. https://orcid.org/0000-0002-2469-0435
Meyer zu Schwabedissen, Henriette E. https://orcid.org/0000-0003-0458-4579
Allemann, Samuel https://orcid.org/0000-0003-4067-9401
Schneider, Cornelia https://orcid.org/0000-0001-9628-691X
Funding for this research was provided by:
University of Basel
Article History
Accepted: 29 January 2025
First Online: 20 February 2025
Declarations
:
: Open access funding provided by University of Basel.
: Christoph R Meier is an editorial board member of Drug Safety and so was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. Nina L Wittwer, Carola A Huber, Henriette E. Meyer zu Schwabedissen, Samuel Allemann, and Cornelia Schneider have no conflicts of interest relevant to this work.
: The datasets generated and/or analysed during the current study are not publicly available because of confidentiality requirements issued by Helsana. Analysis codes and datasets can be made available by the corresponding author (s.allemann@unibas.ch) upon reasonable request and with permission of Helsana.
: Ethics approval was not necessary according to article 22 of the Swiss Federal law on data protection, as the study was retrospective and used anonymized data [].
: Not applicable.
: The datasets generated and/or analysed during the current study are not publicly available due to confidentiality requirements issued by Helsana. Analysis codes and datasets can be made available by the corresponding author (s.allemann@unibas.ch) upon reasonable request and with permission of Helsana.
: All authors contributed to the study conception and design. Carola A Huber acquired the data. Nina L Wittwer and Cornelia Schneider analysed the data. All authors interpreted the data. Nina L Wittwer wrote the first draft of the manuscript, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: In accordance with the Swiss Federal Law on data protection, all data were anonymised and de-identified to safeguard the privacy of patients, physicians, and hospitals. As the data were collected on a routine basis, retrospectively, from existing sources, and de-identified, no informed consent from patients was required, and the study was exempt from ethics committee approval in accordance with Swiss legislation on human research.